Company intelligence / Profile preview

FemTec Health

Houston, Texas, United Statesfemteconline.org ↗

Ownership: Private
Employees: ~150
Development stage: Commercial

Overview

At its peak in late 2021–early 2023, FemTec Health had over $38M in funding,[8] more than ten million members,[4] two clinical trials underway,[4] a staff of over 150,[4], and offered personalized telehealth consultations/products via its BiomeAI™ platform. The company filed for bankruptcy in July 2023.[1]

Therapeutic areas: Men's HealthEndocrinologyRare DiseasesOtherPsychiatryDermatologyNephrologyWomen's Health
Modalities: DeviceNon-pharmacological therapyDiagnosticsSmall molecule
Industry: Non-Academic Healthcare

Partnerships

GeniusRx online pharmacy

Beyond the preview

Go deeper on FemTec Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FemTec Health.

Explore the full profile